Characterization of the weak estrogen receptor alpha agonistic activity of exemestane
- PMID: 18677558
- PMCID: PMC3503449
- DOI: 10.1007/s10549-008-0151-x
Characterization of the weak estrogen receptor alpha agonistic activity of exemestane
Abstract
Third generation aromatase inhibitors (AI) have shown good clinical efficacy in comparison to the anti-estrogen tamoxifen. The steroidal AI, exemestane (EXE) has previously been shown to act as an androgen, but this report demonstrates the estrogen-like activity of EXE. Based on genome-wide microarray analysis, high correlation was seen between EXE-Only (EXE O, hormone-free) and hormone-containing AI-resistant lines. In addition, the top regulated genes in the EXE O lines were mostly estrogen-responsive genes. This estrogen-like activity of EXE was further validated using estrogen receptor (ER) activity assays, where in comparison to 17beta-estradiol (E2), EXE was able to induce ER activity, though at a higher concentration. Also, this EXE-mediated ER activity was blocked by the ER antagonist ICI as well as the ERalpha-specific antagonist methyl-piperidino-pyrazole (MPP). Similarly, EXE was able to induce proliferation of breast cancer cell lines, MCF-7 and MCF-7aro, as well as activate transcription of known estrogen-responsive genes, i.e., PGR, pS2 and AREG. These results suggest that EXE does have weak estrogen-like activity.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3503449/bin/nihms-364377-f0001.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3503449/bin/nihms-364377-f0002.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3503449/bin/nihms-364377-f0003.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3503449/bin/nihms-364377-f0004.gif)
Similar articles
-
The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane.Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165661. doi: 10.1016/j.bbadis.2019.165661. Epub 2019 Dec 28. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 31891807
-
Unravelling exemestane: From biology to clinical prospects.J Steroid Biochem Mol Biol. 2016 Oct;163:1-11. doi: 10.1016/j.jsbmb.2016.03.019. Epub 2016 Mar 15. J Steroid Biochem Mol Biol. 2016. PMID: 26992705 Review.
-
An "omics" approach to determine the mechanisms of acquired aromatase inhibitor resistance.OMICS. 2011 Jun;15(6):347-52. doi: 10.1089/omi.2010.0097. Epub 2011 Feb 19. OMICS. 2011. PMID: 21332390 Free PMC article. Review.
-
Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines.J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):277-82. doi: 10.1016/j.jsbmb.2009.10.011. Epub 2009 Nov 6. J Steroid Biochem Mol Biol. 2010. PMID: 19897035 Free PMC article.
-
Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor.Cancer Res. 2008 Jun 15;68(12):4910-8. doi: 10.1158/0008-5472.CAN-08-0303. Cancer Res. 2008. PMID: 18559539
Cited by
-
An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER+) Breast Cancer: Effects on Sensitive and Resistant Cell Lines.Molecules. 2023 Jan 12;28(2):789. doi: 10.3390/molecules28020789. Molecules. 2023. PMID: 36677847 Free PMC article.
-
Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours.Breast Cancer Res. 2019 Jan 7;21(1):2. doi: 10.1186/s13058-018-1089-5. Breast Cancer Res. 2019. PMID: 30616553 Free PMC article.
-
Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10.J Immunol Res. 2017;2017:3072745. doi: 10.1155/2017/3072745. Epub 2017 Dec 10. J Immunol Res. 2017. PMID: 29464186 Free PMC article.
-
Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.J Med Chem. 2016 Jun 9;59(11):5131-48. doi: 10.1021/acs.jmedchem.5b01281. Epub 2016 Jan 19. J Med Chem. 2016. PMID: 26689671 Free PMC article. Review.
-
Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.J Steroid Biochem Mol Biol. 2016 Jul;161:73-83. doi: 10.1016/j.jsbmb.2015.07.018. Epub 2015 Aug 13. J Steroid Biochem Mol Biol. 2016. PMID: 26277097 Free PMC article. Review.
References
-
- Santner SJ, Chen S, Zhou D, Korsunsky Z, Martel J, Santen RJ. Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. J Steroid Biochem Mol Biol. 1993;44(4–6):611–616. doi:10.1016/0960-0760(93)90267-Z. - PubMed
-
- Yue W, Wang JP, Hamilton CJ, Demers LM, Santen RJ. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res. 1998;58(5):927–932. - PubMed
-
- Miller WR, O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids. 1987;50(4–6):537–548. doi: 10.1016/0039-128X(87)90037-7. - PubMed
-
- Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER. A link between breast cancer and local estrogen biosyn-thesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab. 1993;77(6):1622–1628. doi:10.1210/jc.77.6.1622. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials